-+ 0.00%
-+ 0.00%
-+ 0.00%

The 19% increase in Japan's new drug stock price may hit a halt, thanks to the positive clinical trial results of the Deramiocel drug from partner Capricorn.

智通財經·12/04/2025 01:01:01
語音播報
The 19% increase in Japan's new drug stock price may hit a halt, thanks to the positive clinical trial results of the Deramiocel drug from partner Capricorn.